FEMY - FEMASYS INC

1.12
-0.030   -2.679%

Share volume: 231,557
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.15
-0.03
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 0%
Dept financing 18%
Liquidity 75%
Performance 43%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.88%
1 Month
-20.00%
3 Months
3.70%
6 Months
-2.61%
1 Year
-27.74%
2 Year
8.74%
Key data
Stock price
$1.12
P/E Ratio 
0.00
DAY RANGE
$1.07 - $1.22
EPS 
-$0.85
52 WEEK RANGE
$0.86 - $1.80
52 WEEK CHANGE
-$21.68
MARKET CAP 
25.188 M
YIELD 
N/A
SHARES OUTSTANDING 
22.233 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
1.64
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$300,740
AVERAGE 30 VOLUME 
$615,185
Company detail
CEO: Kathy Lee-Sepsick
Region: US
Website: femasys.com
Employees: 30
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Femasys Inc. focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec. FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing, also commercializes FemVue saline-air device.

Recent news
loading